AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IMMURON LTD

0.058

-0.003-4.92%

Volume:1.36M

Turnover:81.60K

Market Cap:18.73M

PE:-4.50

High:0.065

Open:0.061

Low:0.055

Close:0.061

52wk High:0.098

52wk Low:0.026

Shares:322.85M

Float Shares:265.37M

Volume Ratio:0.54

T/O Rate:0.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.013

EPS(LYR):-0.013

ROE:-40.25%

ROA:-21.67%

PB:1.70

PE(LYR):-4.50

Loading ...

Overview Company News Filings

Australia's Immuron Hits Near 1.5-Month High on Distribution Deal in US

Immuron - Executes Exclusive Distribution Agreement for Proibs in the United States

THOMSON REUTERS

Immuron FY26 Net Sales Rise 6% to AUD 7.7 Million

Immuron Reports FY26 Preliminary Results

THOMSON REUTERS

Immuron Posts FY Revenue from Ordinary Activities of A$7.71 Million

Immuron - Revenue from Ordinary Activities up 5.9% to A$7.71 Mln for Year Ended June 30, 2026

THOMSON REUTERS

Immuron - Loss from Ordinary Activities A$3.8 Mln for Year Ended June 30, 2026

THOMSON REUTERS

Immuron CEO Lydeamore Presents at Emerging Growth Conference

Immuron Posts CEO Presentation for TechKnow Invest Roadshow

Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year

THOMSON REUTERS

Immuron Logs FY Global Sales A$7.7 Million

Immuron - FY26 Global Sales A$7.7 Mln, up 6% on Prior Comparative Period

THOMSON REUTERS

Australia's Immuron Rises as Company Seeks Partnership for New Drug

Immuron - Seeks Partners to Advance Clinical Development of Imm-529

THOMSON REUTERS

Immuron says unaware of undisclosed information behind recent trading move after ASX query

Immuron files Form 3 for Chief Commercial Officer Flavio Palumbo

Immuron files Form 3 as director Daniel Jude Pollock reports beneficial ownership

Immuron files Form 3 for Chairman Paul Gerard Brennan initial beneficial ownership statement

Immuron files Form 3 for Chief Scientific Officer Jerry Kanellos

Immuron files initial beneficial ownership statement for director Jeannette Anne Joughin

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/IMC.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","market":"AU","secType":"STK","nameCN":"IMMURON LTD","latestPrice":0.058,"timestamp":1789020720000,"preClose":0.061,"halted":0,"volume":1357524,"delay":0,"changeRate":-0.04918032786885239,"nameEN":"IMMURON LTD","floatShares":265374293,"shares":322848081,"eps":-0.0129,"marketStatus":"Not Yet Opened","change":-0.003,"latestTime":"09-10 16:12:00 AEST","open":0.061,"high":0.065,"low":0.055,"amount":81598,"amplitude":0.163934,"askPrice":0.058,"askSize":18492,"bidPrice":0.053,"bidSize":50000,"shortable":3,"etf":0,"ttmEps":-0.0129,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.061,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":0.543462,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IMC.AU","preClose":0.061,"auctionPrice":0.061,"auctionVolume":35000,"auction":3,"marketStatus":"盘后竞价","timestamp":1789020164326}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMC.AU\",,,,,undefined,":{"symbol":"IMC.AU","floatShares":265374293,"roa":"-21.67%","roe":"-40.25%","lyrEps":-0.0129,"volumeRatio":0.543462,"shares":322848081,"dividePrice":0,"high":0.065,"amplitude":0.163934,"preClose":0.061,"low":0.055,"week52Low":0.026,"pbRate":"1.70","psRate":"2.43","week52High":0.098,"institutionHeld":0,"latestPrice":0.058,"committee":0.460025,"eps":-0.0129,"divideRate":0,"volume":1357524,"delay":0,"ttmEps":-0.0129,"open":0.061,"prevYearClose":0.036,"prevWeekClose":0.04,"prevMonthClose":0.038,"prevQuarterClose":0.033,"fiveDayClose":0.037,"twentyDayClose":0.039,"sixtyDayClose":0.033},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMC.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2023-02-28","symbol":"IMC.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1677502800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMC.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664863123","title":"Australia's Immuron Hits Near 1.5-Month High on Distribution Deal in US","url":"https://stock-news.laohu8.com/highlight/detail?id=2664863123","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664863123?lang=en_us&edition=fundamental","pubTime":"2026-09-04 11:41","pubTimestamp":1788493288,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immuron hits near 1.5-month high on distribution deal in US** Shares ofAustralia'sImmuronIMC.AXsoar as much as 18.9% to A$0.044,theirhighest since July 20** Stock set forits biggest gainsince August 26** The biopharmaceutical company enters into an exclusive distribution agreement for digestive health productPROIBSin the U.S. withSwedish life science firmCalmino group AB** Nearly935,000shares change hands, around 8.1x 30-day average** YTD, stock up 11.1%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nL4N44W077:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664807855","title":"Immuron - Executes Exclusive Distribution Agreement for Proibs in the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2664807855","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664807855?lang=en_us&edition=fundamental","pubTime":"2026-09-04 07:25","pubTimestamp":1788477919,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V0RG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069805","title":"Immuron FY26 Net Sales Rise 6% to AUD 7.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069805","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662069805?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:00","pubTimestamp":1787911229,"startTime":"0","endTime":"0","summary":"Immuron FY26 net sales rise 6% to AUD 7.7 millionImmuron posted record FY26 net sales of AUD 7.7 million, up 6% from the prior comparative period; second-half net sales rose 7%.FY26 net profit improve","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL52s1wJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BQXX3F31.USD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BQXX3D17.EUR","LU2210150020.SGD","NDAQ","SG9999014005.SGD","LU2095319765.USD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4588","BK4112","SG9999014021.USD","BK7508","IE00BN0W2W23.USD","IMC.AU","BK7067","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069884","title":"Immuron Reports FY26 Preliminary Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662069884?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:00","pubTimestamp":1787911200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUA45KN3T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031128","title":"Immuron Posts FY Revenue from Ordinary Activities of A$7.71 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031128","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031128?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:34","pubTimestamp":1787873652,"startTime":"0","endTime":"0","summary":"BRIEF-Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 MillionAug 28 -Immuron LtdIMC.AX:REVENUE FROM ORDINARY ACTIVITIES UP 5.9% TO A$7.71 MILLION FOR YEAR ENDED JUNE 30, 2026LOSS FROM ORDINARY ACTIVITIES A$3.8 MILLION FOR YEAR ENDED JUNE 30, 2026NO DIVIDENDS PAID OR DECLARED FOR YEAR ENDED JUNE 30, 2026Further company coverage:IMC.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039949","title":"Immuron - Revenue from Ordinary Activities up 5.9% to A$7.71 Mln for Year Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039949","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039949?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:38","pubTimestamp":1787870323,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1PD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039946","title":"Immuron - Loss from Ordinary Activities A$3.8 Mln for Year Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039946","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662039946?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:38","pubTimestamp":1787870323,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1PD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659538801","title":"Immuron CEO Lydeamore Presents at Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2659538801","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659538801?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:06","pubTimestamp":1786615589,"startTime":"0","endTime":"0","summary":"Immuron CEO Lydeamore presents at Emerging Growth ConferenceImmuron CEO Steven Lydeamore will present virtually at the Emerging Growth Conference on Aug. 19, 2026.Slot scheduled for 4:25 p.m. to 4:35 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1G4s0n:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654017922","title":"Immuron Posts CEO Presentation for TechKnow Invest Roadshow","url":"https://stock-news.laohu8.com/highlight/detail?id=2654017922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654017922?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:04","pubTimestamp":1785153842,"startTime":"0","endTime":"0","summary":"Immuron posts CEO presentation for TechKnow Invest RoadshowImmuron published a CEO presentation for the TechKnow Invest Roadshow held today at Sofitel Melbourne on Collins.Presentation highlights Trav","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL8qcsxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMC.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651344388","title":"Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2651344388","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651344388?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:00","pubTimestamp":1784196001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA1KDQZ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651492718","title":"Immuron Logs FY Global Sales A$7.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2651492718","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651492718?lang=en_us&edition=fundamental","pubTime":"2026-07-16 09:26","pubTimestamp":1784165163,"startTime":"0","endTime":"0","summary":"BRIEF-Immuron Logs FY Global Sales A$7.7 MillionJuly 16 (Reuters)-Immuron LtdIMC.AX:FY26 GLOBAL SALES A$7.7 MILLION, UP 6% ON PRIOR COMPARATIVE PERIODFurther company coverage:IMC.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43H1K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMC.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651494298","title":"Immuron - FY26 Global Sales A$7.7 Mln, up 6% on Prior Comparative Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2651494298","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651494298?lang=en_us&edition=fundamental","pubTime":"2026-07-16 08:22","pubTimestamp":1784161372,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43H1K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649610841","title":"Australia's Immuron Rises as Company Seeks Partnership for New Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2649610841","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649610841?lang=en_us&edition=fundamental","pubTime":"2026-07-06 10:45","pubTimestamp":1783305926,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Immuron rises as company seeks partnership for new drug** Shares of Australia's ImmuronIMC.AXrise 11.1% to A$0.040, hitting their highest level since June 4** Stock marks its biggest intraday pct gain since June 1** The biopharmaceutical company says it is employing an advisory firm to help seek a partner to support clinical and commercial development of IMM-529** The IMM-529 is a product that can treat/prevent Clostridioides difficile infection, a contagious bacterial infection of the large intestine** Immuron stock up 11.1%, YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nL4N438046:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMC.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649661126","title":"Immuron - Seeks Partners to Advance Clinical Development of Imm-529","url":"https://stock-news.laohu8.com/highlight/detail?id=2649661126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649661126?lang=en_us&edition=fundamental","pubTime":"2026-07-06 07:19","pubTimestamp":1783293564,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260705:nFWN4350F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638269897","title":"Immuron says unaware of undisclosed information behind recent trading move after ASX query","url":"https://stock-news.laohu8.com/highlight/detail?id=2638269897","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638269897?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:02","pubTimestamp":1779969769,"startTime":"0","endTime":"0","summary":"Immuron told ASX it was not aware of any unannounced information that could explain recent trading in its securities.Pointed to a previously disclosed CEO presentation at the Emerging Growth Conference in the U.S. on May 8, 2026.Confirmed compliance with ASX Listing Rules, including Listing Rule 3.1 on continuous disclosure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL7lhMB0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7508","IMC.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635728717","title":"Immuron files Form 3 for Chief Commercial Officer Flavio Palumbo","url":"https://stock-news.laohu8.com/highlight/detail?id=2635728717","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635728717?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:02","pubTimestamp":1778788976,"startTime":"0","endTime":"0","summary":"Immuron Form 3 showed Chief Commercial Officer Flavio Palumbo held 1,142,909 ordinary shares as of March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL2vQ5Kc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635972871","title":"Immuron files Form 3 as director Daniel Jude Pollock reports beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2635972871","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635972871?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:02","pubTimestamp":1778788925,"startTime":"0","endTime":"0","summary":"Immuron director Daniel Jude Pollock reported ownership of 743,230 ordinary shares as of March 18, 2026.Filing also showed options on 1.33 million ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 14, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL1NzrX6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","IMC.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633962617","title":"Immuron files Form 3 for Chairman Paul Gerard Brennan initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2633962617","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633962617?lang=en_us&edition=fundamental","pubTime":"2026-05-05 06:45","pubTimestamp":1777934756,"startTime":"0","endTime":"0","summary":"Immuron Form 3 filing shows chairman Paul Gerard Brennan holds stock options for 1.67 million ordinary shares, exercisable at USD 0.18 and USD 0.08.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL1T30Jg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631523085","title":"Immuron files Form 3 for Chief Scientific Officer Jerry Kanellos","url":"https://stock-news.laohu8.com/highlight/detail?id=2631523085","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631523085?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:03","pubTimestamp":1777493024,"startTime":"0","endTime":"0","summary":"Immuron Form 3 showed Chief Scientific Officer Jerry Kanellos held 333,000 ordinary shares as of March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDLCZk9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","IMC.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631952344","title":"Immuron files initial beneficial ownership statement for director Jeannette Anne Joughin","url":"https://stock-news.laohu8.com/highlight/detail?id=2631952344","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631952344?lang=en_us&edition=fundamental","pubTime":"2026-04-30 04:01","pubTimestamp":1777492901,"startTime":"0","endTime":"0","summary":"Immuron director Jeannette Anne Joughin filed an initial SEC Form 3 disclosing direct options for 1.33 million ordinary shares at exercise prices of USD 0.09 and USD 0.08.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuron Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL7FJp2c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}